Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 2
1945 2
1946 7
1947 2
1948 3
1949 8
1950 6
1951 4
1952 1
1953 3
1954 4
1955 2
1956 2
1957 8
1958 4
1959 4
1960 5
1961 5
1962 9
1963 6
1964 5
1965 9
1966 6
1967 6
1968 3
1969 5
1970 2
1971 4
1972 3
1973 4
1974 2
1975 4
1976 6
1977 6
1978 6
1979 6
1980 3
1981 3
1982 9
1983 4
1984 3
1985 11
1986 4
1987 12
1988 8
1989 13
1990 7
1991 2
1992 11
1993 7
1994 9
1995 5
1996 5
1997 8
1998 7
1999 8
2000 8
2001 7
2002 15
2003 16
2004 15
2005 13
2006 5
2007 16
2008 19
2009 27
2010 28
2011 22
2012 17
2013 22
2014 26
2015 24
2016 30
2017 25
2018 30
2019 19
2020 24
2021 19
2022 30
2023 17
2024 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

727 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
Deal CL, Steelman J, Vlachopapadopoulou E, Stawerska R, Silverman LA, Phillip M, Kim HS, Ko C, Malievskiy O, Cara JF, Roland CL, Taylor CT, Valluri SR, Wajnrajch MP, Pastrak A, Miller BS. Deal CL, et al. Among authors: silverman la. J Clin Endocrinol Metab. 2022 Jun 16;107(7):e2717-e2728. doi: 10.1210/clinem/dgac220. J Clin Endocrinol Metab. 2022. PMID: 35405011 Free PMC article. Clinical Trial.
Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium.
Bangalore Krishna K, Fuqua JS, Rogol AD, Klein KO, Popovic J, Houk CP, Charmandari E, Lee PA, Freire AV, Ropelato MG, Yazid Jalaludin M, Mbogo J, Kanaka-Gantenbein C, Luo X, Eugster EA, Klein KO, Vogiatzi MG, Reifschneider K, Bamba V, Garcia Rudaz C, Kaplowitz P, Backeljauw P, Allen DB, Palmert MR, Harrington J, Guerra-Junior G, Stanley T, Torres Tamayo M, Miranda Lora AL, Bajpai A, Silverman LA, Miller BS, Dayal A, Horikawa R, Oberfield S, Rogol AD, Tajima T, Popovic J, Witchel SF, Rosenthal SM, Finlayson C, Hannema SE, Castilla-Peon MF, Mericq V, Medina Bravo PG. Bangalore Krishna K, et al. Among authors: silverman la. Horm Res Paediatr. 2019;91(6):357-372. doi: 10.1159/000501336. Epub 2019 Jul 18. Horm Res Paediatr. 2019. PMID: 31319416 Free article. Review.
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration.
Pui CH, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A, Vora A, Baruchel A, Silverman LB, Schmiegelow K, Escherich G, Horibe K, Benoit YC, Izraeli S, Yeoh AE, Liang DC, Downing JR, Evans WE, Relling MV, Mullighan CG. Pui CH, et al. Among authors: silverman lb. J Clin Oncol. 2015 Sep 20;33(27):2938-48. doi: 10.1200/JCO.2014.59.1636. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304874 Free PMC article. Review.
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group. Fenaux P, et al. Among authors: silverman lr. Lancet Oncol. 2009 Mar;10(3):223-32. doi: 10.1016/S1470-2045(09)70003-8. Epub 2009 Feb 21. Lancet Oncol. 2009. PMID: 19230772 Free PMC article. Clinical Trial.
A review of the genetics and epigenetics of central precocious puberty.
Moise-Silverman J, Silverman LA. Moise-Silverman J, et al. Among authors: silverman la. Front Endocrinol (Lausanne). 2022 Dec 2;13:1029137. doi: 10.3389/fendo.2022.1029137. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36531492 Free PMC article. Review.
Corrigendum.
Burns MA, Place AE, Stevenson KE, Gutiérrez A, Forrest S, Pikman Y, Vrooman LM, Harris MH, Weinberg OK, Hunt SK, O'Brien JE, Asselin BL, Athale UH, Clavell LA, Cole PD, Gennarini LM, Kahn J, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Sulis ML, Welch JJG, Neuberg DS, Sallan SE, Silverman LB. Burns MA, et al. Among authors: silverman lb. Pediatr Blood Cancer. 2021 Mar;68(3):e28885. doi: 10.1002/pbc.28885. Epub 2020 Dec 31. Pediatr Blood Cancer. 2021. PMID: 33506554 No abstract available.
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
Whitlock JA, Malvar J, Dalla-Pozza L, Goldberg JM, Silverman LB, Ziegler DS, Attarbaschi A, Brown PA, Gardner RA, Gaynon PS, Hutchinson R, Huynh VT, Jeha S, Marcus L, Messinger Y, Schultz KR, Cassar J, Locatelli F, Zwaan CM, Wood BL, Sposto R, Gore L. Whitlock JA, et al. Among authors: silverman lb. Pediatr Blood Cancer. 2022 Nov;69(11):e29901. doi: 10.1002/pbc.29901. Epub 2022 Aug 21. Pediatr Blood Cancer. 2022. PMID: 35989458
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus.
Schmiegelow K, Attarbaschi A, Barzilai S, Escherich G, Frandsen TL, Halsey C, Hough R, Jeha S, Kato M, Liang DC, Mikkelsen TS, Möricke A, Niinimäki R, Piette C, Putti MC, Raetz E, Silverman LB, Skinner R, Tuckuviene R, van der Sluis I, Zapotocka E; Ponte di Legno toxicity working group. Schmiegelow K, et al. Among authors: silverman lb. Lancet Oncol. 2016 Jun;17(6):e231-e239. doi: 10.1016/S1470-2045(16)30035-3. Lancet Oncol. 2016. PMID: 27299279 Free article. Review.
727 results